Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Jiskoot

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
Journal of Pharmaceutical Sciences|September 2, 2020
Advanced Therapy Medicinal Products: What's in a Name?Wim Jiskoot
Expert Opinion on Drug Delivery|November 22, 2005
Innovative therapeutics: from molecules to medicines. 27 June-7 July 2004, Parma, ItalyWim Jiskoot, Patrizia Santi
Expert Opinion on Drug Delivery|November 19, 2015
Sizing the optimal dimensions of a vaccine delivery system: a particulate matterBram Slütter, Wim Jiskoot
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 6, 2010
Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccinationBram Slütter, Wim Jiskoot
Journal of Pharmaceutical Sciences|June 28, 2012
Models for evaluation of relative immunogenic potential of protein particles in biopharmaceutical protein formulationsRichard Johnson, Wim Jiskoot
Nature Biotechnology|June 10, 2006
Eprex-associated pure red cell aplasia and leachatesHuub Schellekens, Wim Jiskoot
Journal of Immunotoxicology|October 30, 2008
Erythropoietin-Associated PRCA: Still an Unsolved MysteryHuub Schellekens, Wim Jiskoot
Journal of Pharmaceutical Sciences|October 17, 2014
Measurement of the average mass of proteins adsorbed to a nanoparticle by using a suspended microchannel resonatorM Reza Nejadnik, Wim Jiskoot
Pharmaceutical Research|July 12, 2011
Immunogenicity of therapeutic proteins: the use of animal modelsVera Brinks, Wim Jiskoot, Huub Schellekens
Pharmaceutical Research|January 4, 2008
Extrinsic fluorescent dyes as tools for protein characterizationAndrea Hawe, Marc Sutter, Wim Jiskoot
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Journal of Pharmaceutical Sciences|September 2, 2020
Advanced Therapy Medicinal Products: What's in a Name?Wim Jiskoot
Expert Opinion on Drug Delivery|November 22, 2005
Innovative therapeutics: from molecules to medicines. 27 June-7 July 2004, Parma, ItalyWim Jiskoot, Patrizia Santi
Expert Opinion on Drug Delivery|November 19, 2015
Sizing the optimal dimensions of a vaccine delivery system: a particulate matterBram Slütter, Wim Jiskoot
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 6, 2010
Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccinationBram Slütter, Wim Jiskoot
Journal of Pharmaceutical Sciences|June 28, 2012
Models for evaluation of relative immunogenic potential of protein particles in biopharmaceutical protein formulationsRichard Johnson, Wim Jiskoot
Nature Biotechnology|June 10, 2006
Eprex-associated pure red cell aplasia and leachatesHuub Schellekens, Wim Jiskoot
Journal of Immunotoxicology|October 30, 2008
Erythropoietin-Associated PRCA: Still an Unsolved MysteryHuub Schellekens, Wim Jiskoot
Journal of Pharmaceutical Sciences|October 17, 2014
Measurement of the average mass of proteins adsorbed to a nanoparticle by using a suspended microchannel resonatorM Reza Nejadnik, Wim Jiskoot
Pharmaceutical Research|July 12, 2011
Immunogenicity of therapeutic proteins: the use of animal modelsVera Brinks, Wim Jiskoot, Huub Schellekens
Pharmaceutical Research|January 4, 2008
Extrinsic fluorescent dyes as tools for protein characterizationAndrea Hawe, Marc Sutter, Wim Jiskoot
Pageof 28